Cencora (WBO:ABC) Payments of Debt: €-63,932 Mil (TTM As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
67 GF Score
Price €256.60
GF Value €252.90
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Payments of Debt?

Cencora WBO:ABC +2.15% 67 Payments of Debt is €-63,932 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 67/100 and a GF Value™ of €252.90 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Payments of Debt for the three months ended in Mar. 2026 was €-41,210 Mil.

Cencora's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €-63,932 Mil.

Cencora Payments of Debt Related Terms

Cencora Payments of Debt Historical Data

* Premium members only.

The historical data trend for Cencora's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Payments of Debt Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,031.36 -5,970.01 -74,022.29 -63,769.91 -113,696.88

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27,772.99 -75,445.34 72,906.66 -20,182.67 -41,210.24
WBO:ABC
67GF Score
Cencora Inc WBO:ABC
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-63,932 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €-63,932 Mil mean?
Cencora (WBO:ABC) has a Payments of Debt of €-63,932 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Cencora and its competitors.
Is Cencora's Payments of Debt too high?
Cencora's current Payments of Debt is €-63,932 Mil. Overall, Cencora has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Payments of Debt compare to CAH and MCK?
Cencora's Payments of Debt of €-63,932 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Distribution company?
A good Payments of Debt depends on the Medical Distribution industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Cencora and its competitors. Cencora's current Payments of Debt is €-63,932 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €252.90, compared to a current price of €256.60 — trading 1.5% above its estimated fair value. The current Payments of Debt is €-63,932 Mil. Cencora's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Payments of Debt is €-63,932 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €256.60 is trading 1.5% above its estimated GF Value™ of €252.90. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Payments of Debt: €-63,932 Mil
  • GF Value™: €252.90 vs. price of €256.60 (1.5% above fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
67GF Score

Get the complete analysis for WBO:ABC

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€256.60
Price
€252.90
GF Value